ERBB2 and breast carcinoma: One solution is to identify overexpressed antigens to differentiate healthy cells form cancer cells, with some examples being human epidermal growth factor receptor (HER2) and MUC1 related to the breast cancer or cluster of differentiate 20 (CD20) related to the B cell lymphoma [3,4,5,6].